Learn about the latest research in oligomerization and mitochondrial dysfunction in Parkinson’s disease
Dr. Sonia Gandhi
Dr Sonia Gandhi is a Group Leader at The Francis Crick Institute and a Professor of Neurology at UCL. Her research focuses on understanding various cellular mechanisms of neurodegeneration, especially in Parkinson’s disease (PD). Her team focuses on protein misfolding and mitochondrial dysfunction.
Recently, she partnered with a group of synthetic chemists and produced a molecule called “CAP-1” that binds with high affinity to protein oligomers and could be used in the future to detect and characterise the aggregates that initiate and drive the development of neurodegenerative disorders like PD.